← FDA DRUG APPROVALS

FDA ANDA · ANDA078015

TAMSULOSIN HYDROCHLORIDE

Sponsor: SANDOZ

APPLICATION
ANDA078015
TYPE
ANDA
ORIGINAL APPROVAL
2010-04-27
LATEST ACTION
2021-09-15
ROUTE
ORAL
DOSAGE FORM
CAPSULE
MARKETING STATUS
Discontinued

Products

TAMSULOSIN HYDROCHLORIDEDiscontinued
TAMSULOSIN HYDROCHLORIDE 0.4MG · CAPSULE · ORAL

Approval history

2021-09-15Labeling · Supplement 14 · standardAP
2021-09-15Manufacturing (CMC) · Supplement 13 · unknownAP
2015-10-30Labeling · Supplement 7 · standardAP
2011-10-27Labeling · Supplement 5AP
2011-05-04Labeling · Supplement 3AP
2010-04-27OriginalAP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industryGMP disciplineFDA drug shortagesFDA enforcement & recalls

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →